FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4309677154> ?p ?o ?g. }

• W4309677154 endingPage "100170" @default.
• W4309677154 startingPage "100170" @default.
• W4309677154 abstract "Tirbanibulin 1% ointment is approved for the topical treatment of actinic keratosis, applied once daily for 5 days. Three phase 1 randomized, single-center, controlled, within-subject comparison studies were conducted to evaluate the sensitization (KX01-AK-006), phototoxic (KX01-AK-008), and photoallergic (KX01-AK-009) potential of tirbanibulin 1% ointment in healthy adults. In KX01-AK-006 and KX01-AK-009, subjects received repeated applications of tirbanibulin or vehicle for induction (followed by irradiation in KX01-AK-009) and an additional application for the challenge on naïve sites. In KX01-AK-008, subjects received single applications, followed by irradiation. Sensitization was defined as a reaction scoring 3 at naïve sites, recurring at rechallenge. Photoallergy was assessed based on the dermal response of erythema + edema at naïve sites. Phototoxicity was assessed based on the average dermal response score (days 3‒4). Adverse events were collected. In KX01-AK-006, none of the 229 subjects scored 3 at naïve sites. In KX01-AK-008, none of the 31 subjects developed edema, not meeting the criteria for phototoxicity. In KX01-AK-009, none of the 59 subjects showed reactions compatible with photoallergy. Mild-to-moderate contact irritations were reported. The evidence provided by these phase 1 studies showed that tirbanibulin 1% ointment lacks sensitization and phototoxic or photoallergic potential, and supports the safety of its topical application. Tirbanibulin 1% ointment is approved for the topical treatment of actinic keratosis, applied once daily for 5 days. Three phase 1 randomized, single-center, controlled, within-subject comparison studies were conducted to evaluate the sensitization (KX01-AK-006), phototoxic (KX01-AK-008), and photoallergic (KX01-AK-009) potential of tirbanibulin 1% ointment in healthy adults. In KX01-AK-006 and KX01-AK-009, subjects received repeated applications of tirbanibulin or vehicle for induction (followed by irradiation in KX01-AK-009) and an additional application for the challenge on naïve sites. In KX01-AK-008, subjects received single applications, followed by irradiation. Sensitization was defined as a reaction scoring 3 at naïve sites, recurring at rechallenge. Photoallergy was assessed based on the dermal response of erythema + edema at naïve sites. Phototoxicity was assessed based on the average dermal response score (days 3‒4). Adverse events were collected. In KX01-AK-006, none of the 229 subjects scored 3 at naïve sites. In KX01-AK-008, none of the 31 subjects developed edema, not meeting the criteria for phototoxicity. In KX01-AK-009, none of the 59 subjects showed reactions compatible with photoallergy. Mild-to-moderate contact irritations were reported. The evidence provided by these phase 1 studies showed that tirbanibulin 1% ointment lacks sensitization and phototoxic or photoallergic potential, and supports the safety of its topical application." @default.
• W4309677154 created "2022-11-29" @default.
• W4309677154 creator A5011344224 @default.
• W4309677154 creator A5015685796 @default.
• W4309677154 creator A5077396562 @default.
• W4309677154 creator A5087406992 @default.
• W4309677154 date "2023-03-01" @default.
• W4309677154 modified "2023-10-01" @default.
• W4309677154 title "Contact Sensitization and Phototoxic and Photoallergic Potential of Tirbanibulin 1% Ointment in Healthy Volunteers" @default.
• W4309677154 cites W1996274389 @default.
• W4309677154 cites W2015051737 @default.
• W4309677154 cites W2338659878 @default.
• W4309677154 cites W2808974751 @default.
• W4309677154 cites W3104095770 @default.
• W4309677154 cites W3126541971 @default.
• W4309677154 cites W3213070514 @default.
• W4309677154 doi "https://doi.org/10.1016/j.xjidi.2022.100170" @default.
• W4309677154 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36699198" @default.
• W4309677154 hasPublicationYear "2023" @default.
• W4309677154 type Work @default.
• W4309677154 citedByCount "1" @default.
• W4309677154 countsByYear W43096771542023 @default.
• W4309677154 crossrefType "journal-article" @default.
• W4309677154 hasAuthorship W4309677154A5011344224 @default.
• W4309677154 hasAuthorship W4309677154A5015685796 @default.
• W4309677154 hasAuthorship W4309677154A5077396562 @default.
• W4309677154 hasAuthorship W4309677154A5087406992 @default.
• W4309677154 hasBestOaLocation W43096771541 @default.
• W4309677154 hasConcept C141071460 @default.
• W4309677154 hasConcept C16005928 @default.
• W4309677154 hasConcept C168563851 @default.
• W4309677154 hasConcept C185592680 @default.
• W4309677154 hasConcept C197934379 @default.
• W4309677154 hasConcept C202751555 @default.
• W4309677154 hasConcept C203014093 @default.
• W4309677154 hasConcept C204243189 @default.
• W4309677154 hasConcept C20639190 @default.
• W4309677154 hasConcept C2776217527 @default.
• W4309677154 hasConcept C2779121184 @default.
• W4309677154 hasConcept C2780886150 @default.
• W4309677154 hasConcept C55493867 @default.
• W4309677154 hasConcept C71924100 @default.
• W4309677154 hasConcept C98274493 @default.
• W4309677154 hasConceptScore W4309677154C141071460 @default.
• W4309677154 hasConceptScore W4309677154C16005928 @default.
• W4309677154 hasConceptScore W4309677154C168563851 @default.
• W4309677154 hasConceptScore W4309677154C185592680 @default.
• W4309677154 hasConceptScore W4309677154C197934379 @default.
• W4309677154 hasConceptScore W4309677154C202751555 @default.
• W4309677154 hasConceptScore W4309677154C203014093 @default.
• W4309677154 hasConceptScore W4309677154C204243189 @default.
• W4309677154 hasConceptScore W4309677154C20639190 @default.
• W4309677154 hasConceptScore W4309677154C2776217527 @default.
• W4309677154 hasConceptScore W4309677154C2779121184 @default.
• W4309677154 hasConceptScore W4309677154C2780886150 @default.
• W4309677154 hasConceptScore W4309677154C55493867 @default.
• W4309677154 hasConceptScore W4309677154C71924100 @default.
• W4309677154 hasConceptScore W4309677154C98274493 @default.
• W4309677154 hasIssue "2" @default.
• W4309677154 hasLocation W43096771541 @default.
• W4309677154 hasLocation W43096771542 @default.
• W4309677154 hasLocation W43096771543 @default.
• W4309677154 hasOpenAccess W4309677154 @default.
• W4309677154 hasPrimaryLocation W43096771541 @default.
• W4309677154 hasRelatedWork W1976160908 @default.
• W4309677154 hasRelatedWork W1984063448 @default.
• W4309677154 hasRelatedWork W1995958369 @default.
• W4309677154 hasRelatedWork W2031913140 @default.
• W4309677154 hasRelatedWork W2154977249 @default.
• W4309677154 hasRelatedWork W2158223641 @default.
• W4309677154 hasRelatedWork W2320241196 @default.
• W4309677154 hasRelatedWork W2412825974 @default.
• W4309677154 hasRelatedWork W248296967 @default.
• W4309677154 hasRelatedWork W3021533955 @default.
• W4309677154 hasVolume "3" @default.
• W4309677154 isParatext "false" @default.
• W4309677154 isRetracted "false" @default.
• W4309677154 workType "article" @default.